Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/23265| Title: | Caution in adding bevacizumab in the adjuvant treatment of breast cancer |
| Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
| Keywords: | Angiogenesis Inhibitors/*therapeutic use,Antibodies, Monoclonal/*therapeutic use,Antibodies, Monoclonal, Humanized,Antineoplastic Combined Chemotherapy Protocols,Chemotherapy, Adjuvant,Colonic Neoplasms/*drug therapy,Female,Humans,Vascular Endothelial Growth Factor A/antagonists & inhibitors |
| URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/23265 |
| ISSN: | 1534-4681 |
| Link: | http://www.ncbi.nlm.nih.gov/pubmed/19888632 http://www.springerlink.com/content/0u2201325m024641/fulltext.pdf |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Ziogas-2010-Caution in adding be.pdf | 133.78 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
